A COVID-19 family cluster with retinitis pigmentosa and hypogammaglobulinemia.
Ann Thorac Med
; 17(1): 66-69, 2022.
Article
in English
| MEDLINE | ID: covidwho-1629729
ABSTRACT
Hypogammaglobulinemia is a heterogeneous group of innate and acquired antibody deficiency with variable disease severity, recurrent pneumonia, and bronchiectasis. The outcome of COVID in patients with hypogammaglobulinemia is variable depending on age, comorbidities, type of immunodeficiency, and use of immunoglobulins. We report the favorable outcome of two family members diagnosed with DNAJC17-related retinitis pigmentosa and hypogammaglobulinemia syndrome and infected with SARS-CoV-2 following contact with their mother who had COVID-19. We describe the different immune dysfunction in these patients and their impact on the course and management of SARS-CoV-2 infection.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Type of study:
Prognostic study
Language:
English
Journal:
Ann Thorac Med
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS